| Literature DB >> 6896886 |
C J Robinson, E Spanos, M F James, J W Pike, M R Haussler, A M Makeen, C J Hillyard, I MacIntyre.
Abstract
Intestinal calcium absorption and plasma levels of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) were measured in lactating and non-lacting rats and the effects of bromocriptine and exogenous prolactin treatment were evaluated. In lacting rats calcium absorption and plasma levels of parathyroid hormone, 1,25(OH)2D3 and alkaline phosphatase activity were significantly increased. Bromocriptine treatment significantly reduced the enhanced calcium absorption and levels of plasma 1,25(OH)2D3 and alkaline phosphatase but had no significant effect on plasma levels of parathyroid hormone. Prolactin administered with bromocriptine to lactating animals prevented all the changes observed with bromocriptine treatment alone. It was concluded that the increased plasma levels of prolacting during lactation lead to high plasma levels of 1,25(OH)2D3 which are responsible for the enhanced intestinal calcium absorption.Entities:
Mesh:
Substances:
Year: 1982 PMID: 6896886 DOI: 10.1677/joe.0.0940443
Source DB: PubMed Journal: J Endocrinol ISSN: 0022-0795 Impact factor: 4.286